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Immunological self/not-self discrimination is conventionally seen as an extracellular event, 
involving interactions been receptors on T cells pre-educated to discriminate, and peptides 
bound to major histocompatibility complex proteins (pMHCs). Mechanisms by which not-self 
peptides might first be sorted intracellularly to distinguish them from the vast excess of self-
peptides have long been called for. Recent demonstrations of endogenous peptide-specific 
clustering of pMHCs on membrane rafts are indicative of intracellular enrichment before 
surface display. The clustering could follow the specific aggregation of a foreign protein that 
exceeded its solubility limit in the crowded intracellular environment. Predominantly 
entropy-driven, this homoaggregation would co-localize identical peptides, so facilitating 
their collective presentation. Concentrations of self-proteins are fine-tuned over evolutionary 
time to avoid this. Disparate observations, such as pyrexia, and female susceptibility to 
autoimmune disease, can be explained in terms of the need to cosegregate cognate pMHC 
complexes internally prior to extracellular display. 
Key words: differential avidity, macromolecular crowding, protein aggregation, TCR cross-
linking, thymic cortex and medulla, X chromosome dosage compensation 
 
INTRODUCTION   
The predictions that the shaping of lymphocyte repertoires to meet future antigenic (e.g. viral) 
challenges requires both positive and negative selection
1
 and that, for this purpose, 
‘promiscuous’ tissue-restricted antigens (TRAs) are ectopically displayed in a central lymphoid 
organ (e.g. thymus),
2
 have been confirmed in many laboratories.
3,4
 Reactions between the 
receptors on T cells (TCRs) that have been ‘educated’ in this way, and peptides bound by major 
histocompatibility complex proteins (pMHCs) on antigen presenting cells (APCs), appear to 
provide sufficient self/not-self discrimination to prevent self-reactivity. However, recently there 
has been support for the prediction that this extracellular self/not-self discrimination is 
supplemented by prior intracellular discrimination.
5
 Lu et al. reported in 2012
6
 that, before 
pMHC display, “endogenous antigen processing generates intracellular clusters of class I 
molecules segregated on the basis of their peptide cargo.” While confirming the high specificity 
of this colocation of cognate pMHC complexes, Ferez et al. in 2014
7
 regretted that the 
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mechanism of the “preferential loading of newly synthesized MHC class 1 loading with viral 
peptides,” remained problematic.  
Indeed these, and many other spectacular advances, bring to light as many problems as they 
solve. Both centrally and peripherally the TCR specificity of T cells is set to anticipate future 
pathogens, but how did this evolve? Why is there less redundancy of TCR binding (less cross-
reactivity) than first thought? Why are there ‘coexpression groups’ of TRAs, and why is there 
mosaic, not ubiquitous, TRA expression in medullary thymic epithelial cells (mTECs)? Why do 
the self-peptides isolated from MHC proteins usually correspond to large and abundant proteins? 
Is it better to think in terms of TCR affinity or avidity?  
Then there are the much broader questions that are not usually dealt with in this context. 
When the crunch comes, is it more important to respond to foreign or prevent reaction with self? 
Why are females more prone to autoimmune disease? What is the adaptive value, if any, of 
pyrexia? Can T lymphocyte reactivity with polyclonal mitogens (e.g. lectins) tell us anything 
about reactivity with specific antigens? Why in infectious and autoimmune diseases are there 
changes in plasma such that erythrocytes aggregate into rouleaux that sediment rapidly in 
isolated blood samples? 
The latter, known clinically as the increased ESR (erythrocyte sedimentation rate),
8
 focused 
attention on ‘macromolecular crowding’ and the many clinical disorders associated with specific 
extracellular or intracellular protein aggregates. The present paper relates a two decade old 
hypothesis on the role of protein aggregation in intracellular self/not-self discrimination
5
 to new 
developments in our understanding of pMHC presentation and thymic function. While still far 
from definitive, that the proposed mechanism appears to unify the many disparate problems 
listed above, suggests review is timely.   
 
THE NEAR-SELF REPERTOIRE  
A two signal hypothesis
9,10
 postulated a distinction, at the level of individual immunologically-
competent cells, between those specific antigenic signals that activate, and those that inhibit. 
Although the division is not absolute, a comparable cell fate duality maps for T lymphocytes to 
two thymic locations. Activation signals associated with positive repertoire selection locate 
mainly to the cortex, and inhibitory signals associated with negative repertoire selection locate 
mainly to the medulla.
4
 After endowment, in a quasi-random manner, with a wide range of 
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specificities, developing thymocytes proceed from cortex to medulla, running sequentially the 
gauntlets of positive and negative selection. The few that ‘audition’ successfully enter the 
peripheral lymphoid system.  
Ideally this somatic ‘education’ process would remove self-reactivity and anticipate reactivity 
to foreign ‘not-self’ antigens. However, given that specific foreign challenges are often from 
microorganisms with higher mutation rates than those of their hosts, such anticipation would 
seem in vain. Similarly, the notion that, over evolutionary time, there is germ-line selection of 
prospective hosts with MHCs preadapted for such challenges, is increasingly seen as 
unlikely.
11,12
 Thus, the view that there cannot be germ-line information for anticipating the 
specific immunological challenges of future generations – i.e. they must start with neutral ‘blank 
slates’ – has grown more secure. Nevertheless, the possibility that immunological repertoires 
might become skewed during somatic time to the advantage of hosts emerged when the process 
was examined from the perspective of pathogens.
1
 
A microbe that could, in one step, mutate one of its antigens from a form that was not-self 
with respect to its host, to a form that was self with respect to its host, would have largely 
overcome the host’s immune defences with respect to that antigen. It could then exploit the 
‘holes’ in the repertoire that had been created by the host’s prior elimination of self-reacting 
lymphocytes. However, mutation is generally a stepwise process. If a microbe (not-self), by 
mutating a step towards self along the path from not-self to self, could secure a selective 
advantage, then the mutant form would come to dominate the microbe population. If a microbe 
from this mutant population, by mutating a further step along the path, secured a further 
advantage, then this new mutant form would, in turn, come to dominate the population. Thus, an 
average member of the microbe population would progressively become better adapted, to the 
detriment of the host. This supposes that progressive mutation along the not-self-to-self path 
would be increasingly advantageous to the microbe. However, the advantage would be lost if, as 
it mutated closer to host-self, the microbe encountered progressively stiffer host defences. Thus, 
positive selection of lymphocytes for specificities that were very close to, but not quite, anti-self 
– that is anti-‘near-self’ specificities – could be an important host adaptation.1  
Indeed, it is now recognized, both that positive selection of T cells of intermediate affinity for 
‘near-self’ shapes immunological repertoires,3,13–16 and that the repertoires so-skewed can 
achieve selective high affinity targeting of  pathogens.
17
 In 2013 Mandl et al.
18
 observed: "TCRs 
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able to bind self pMHC well (but below the negative selection threshold) also bind especially 
well to foreign pMHC and hence … positive selection ensures that T cells most useful for host 
defense against pathogens are selected from a diverse initial repertoire to populate the peripheral 
T cell pool." Thus, “the raison d’être of positive selection … is to bias T cell selection towards 
strongly self-reactive clones that are endowed with a homeostatic advantage and a head start in 
anti-pathogen responses”.4 Cancro and Kearney19 have written similarly on the ‘education’ of B 
lymphocytes whose receptors share “parallel strategies of antigen recognition” with T cells.11 
In this way, by anticipating their mutational strategies, a host can, albeit indirectly, have prior 
knowledge of pathogens. Such reasoning questions the notion that heterozygote advantage drives 
the evolution of MHC polymorphism.
20,21
 In 2004 Borghans et al.
22
 calculated that: “Host-
pathogen coevolution … can easily account for realistic polymorphisms of even more than 50 
alleles per MHC locus." Furthermore, focusing on ‘near-self’ (i.e. limited cross-reactivity) 
greatly reduces the need for TCR binding degeneracy to cope with the universe of potential 
peptide challengers.
23,24
 
The somatic ‘education’ of lymphocytes is not confined to central lymphoid organs, but is 
ongoing.
25
 Indeed, successful ‘auditioners’ that escape from central to peripheral lymphoid 
tissues are kept tuned to near-self and maintained in a state of constant readiness through ‘tonic’ 
low affinity interactions with near-self antigens that deliver survival signals, but do not initiate 
proliferation in the absence of general homeostatic signals.
26
 Thus, there is “a link between 
thymic pMHC experience and mature T cell homeostasis”.4 A lymphocyte ‘preactivated’ in this 
way is poised to respond. The onus is then on APCs to present appropriate high affinity pMHCs 
when circumstances so warrant. 
In addition to the thymic cortex/medulla locational duality, the modes of antigen presentation 
by different types of antigen-presenting cells (APC) in these two locations differ profoundly. We 
here review how an understanding of the latter duality can relate both to two signal ideas,
1,9
 and 
to the postulate of a  two-step self/not-self discrimination processes – first an intracellular 
discrimination, and then an extracellular discrimination mediated by ‘educated’ T lymphocytes.5 
SELF PEPTIDES AS DISTRACTORS 
Amidst a sea of near-self pMHCs for which they have intermediate affinity, peripheral αβ TCR 
lymphocytes are kept in constant readiness for the rarer high affinity complexes that should focus 
them to the displaying cell, be it a ‘professional’ APC with pMHC directed to CD4 and CD8 
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coreceptor T cells, or another cell type with pMHC directed to CD8 T cells. The need for an 
urgent response suggested by the state of constant readiness, indicates advantages in APC 
mechanisms that could focus attention on newly arising high affinity pMHCs derived from not-
self peptides, so avoiding distraction by the large excess of intermediate affinity pMHCs derived 
from self-peptides. This made attractive, hypotheses that peptides from freshly synthesized 
partial or complete proteins might somehow be selectively channeled to pMHCs. Thus, views 
that peptides were formed from incompletely synthesized proteins – ‘defective ribosome 
products’ (DRiPs) or ‘pioneer translation products’ (PTPs) – gained much attention.27,28 
However, two recent advances make timely the recalling of an alternative mechanism.
5
 First, 
views that peptides are formed from DRiPs or PTPs are now contested by evidence that peptides 
in pMHC complexes derive from native, fully synthesized, properly folded, proteins. These 
mature proteins can be degraded to peptides at any time after synthesis and are not necessarily 
‘retirees’ that are part of normal protein turnover.29–31 Indeed, from studies of an intracellular 
parasite that secretes only mature proteins into host cytosol, Wolf and Princiotta
32
 conclude that 
“presentation efficiency may be higher for proteins that enter the cellular pool when compared 
with those processed in a near cotranslational manner, such as endogenously synthesized … 
DRiPs.” Second, there is a better understanding of how APC in the thymic cortex (cortical 
thymic epithelial cells; cTECs), differ in peptide-generation mechanisms from various APC in 
the thymic medulla (including medullary thymic epithelial cells; mTECs). Medullary peptide-
generation mechanisms more closely resemble those found in peripheral APCs.
4
 Can the division 
of labour – cTECs relating to positive selection and mTECs relating to negative selection – tell 
us something about peptide sorting mechanisms and the distinction between signals that activate, 
and those that inhibit? We first consider how a signal that activates at one time may inhibit at 
another, so the distinction must be seen in context. 
ANTIGEN DOSE OPTIMUM SHIFTS  
Autoimmune diseases, reflecting a failure of negative selection, are usually of slowly increasing 
severity, whereas attacks by microbial pathogens, requiring positive selection, often need urgent 
responses. Assuming a duality related to antigen dosage, and that dosage would be low at early 
time points, it would seem more likely a priori that a low dose of an antigen would suffice for 
positive selection of responding lymphocytes, whereas a high dosage would be required for their 
negative selection. Building on the observations that (i) an effective form of immunological 
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tolerance is, indeed, antigen dose-dependent – high doses being tolerogenic,33 and (ii) activation 
of cultured lymphocytes by a polyclonal mitogen is an all-or-none (‘digital’) phenomenon,34 a 
two signal hypothesis
9
 proposed that low doses would provide the signal to a lymphocyte for an 
immune response (positive selection) and high doses would tolerize (negative selection; clonal 
deletion). Indeed, it was found, that high concentrations of a polyclonal mitogen deleted cultured 
lymphocytes, that deletion was complement-dependent, and that it involved cross-linking of cell-
borne receptors.
35,36
 There is now evidence, for both CD4 and CD8 T cells, that one pMHC can 
activate and that two or more pMHCs can kill.
37,38
 However apoptosis, rather than complement, 
appears as the agency.   
Urgency of activation relative to inhibition is supported by in vitro murine antigen dose-
response studies by Alexander-Miller et al..
39 
At early time-points the function (cytotoxic 
activity) of T cells progressively increases with antigen dose. However, at later time-points the 
higher antigen dosages are inhibitory. Thus a concentration that appears optimum at late time 
points is less than the optimum as assessed at earlier time points. Similar optimum shifts are seen 
with lymphocytes cultured with varying doses of antigens or polyclonal mitogens.
40,41
 
Furthermore, the late-onset high dose inhibition begins at lower dosages with high avidity 
antigens.
39,42
 Optimum shifts can also appear in vivo. In 1964 Mitchison found that high dose 
tolerance was of late onset following an initial immunogenic phase.
33
 In 1996 Liblau et al. found 
that, whereas thymocyte tolerance induced by high antigen dosage was rapid, peripheral 
tolerance followed a period of lymphocyte activation.
43  
THYMIC POSITIVE AND NEGATIVE SELECTION 
Following Occam’s razor, in 1999 Barton and Rudensky44 thought “it would be reasonable for 
the immune system to evaluate T cells during development on the basis of the rules of 
recognition that are required in the periphery.” Thus, by analogy with the signaling duality in 
peripheral lymphocytes (see above), thymic positive selection might require low antigen dosage, 
and thymic negative selection might require high antigen dosage. However, the thymic cortex is 
distinct from the periphery in that it is a site for generation of wide TCR diversity, with apoptotic 
loss ‘by neglect’ of those cells whose TCRs do not achieve a minimum level of affinity for the 
pMHCs displayed by cTECs.  Only when members of such a ‘preselection repertoire’ have been 
generated can they be subjected to positive selection for cells with TCRs of moderate and high 
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affinity for self pMHCs. In this process they may be activated to some degree,
45
 but proliferation 
ceases.
46
 Indeed, since many cells are to be negatively selected, proliferation would seem 
unnecessary at this stage. 
Nevertheless, the activation might follow the ‘rules of recognition’ operative in the periphery. 
But whereas mature peripheral lymphocytes can be activated by polyclonal activators (lectins), 
thymocytes cannot.
47
 Furthermore, activation of the ‘preselection repertoire’ is indifferent to the 
CD4 or CD8 nature of coreceptors, and only needs to be permissive or non-permissive – above a 
critical threshold (below which ‘neglect’ would be in play) activation needs to depend neither on 
affinity for, nor the actual dosage of, the activating pMHC. In other words, there is wide affinity 
window.
48
 Thus, there would be no need for cTECs to generate large quantities of individual 
proteins in order to generate peptides.
44
 Indeed, ‘preselection repertoire’ diversity might be 
maximized if the resources for protein production were devoted to producing many proteins, 
rather than large quantities of individual proteins. In this circumstance, as suggested by Linsk et 
al. in 1989,
2
 a low level of whole genome ‘transcriptional noise’ – otherwise ‘illegitimate,’ 
‘ectopic,’ or ‘leaky’ transcription – might suffice to produce sufficient quantities of each protein 
for positive selection.
49
 
On the other hand, thymic negative selection requires high concentrations of individual 
proteins. A well-studied example is proinsulin, where a polymorphic variant associated with high 
thymic expression spares humans from type 1 diabetes.
50
 Likewise for rodents Kyewski and 
Klein
51
 note “the … exquisite sensitivity of the central tolerance process to moderate quantitative 
variations in TRA expression. Thus, subtle differences in the range of two- to fourfold in 
intrathymic expression of auto-antigens as obtained in mice with defined copy numbers of 
pancreatic or nervous system-specific antigens can modulate the susceptibility to autoimmunity.”  
A need for high concentrations implies that each mTEC would limit the diversification of its 
proteins, so that its resources for protein production could better produce large quantities of a 
few proteins from which corresponding pMHCs would be produced.
2
 This would be consistent 
with a dramatic difference between cTECs and mTECS – namely the mosaic location within 
distinctive medullary sectors of the specific pMHC-bearing mTECs that ‘promiscuously’ 
synthesize different TRAs. It is estimated that, at given time, only 1–3% of mTECs produce a 
particular antigen.
52
 While currently there is much concern about differences between cTECS 
and mTECs in the qualitative characteristics of the peptides produced – cTECs generate a unique 
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“MHC ligandome”4 – this could be merely ancillary to the need to optimize these two different 
roles.  
Nevertheless, one qualitative characteristic of a mature protein from which peptides are 
derived is important – its function. Once synthesized within the thymus, a promiscuous gene 
product is not needed for its function, but for its components. A need for high quantities raises 
the prospect of a degree of ectopic function that could endanger the cell. For this reason, it would 
be predicted, first, that there would be an intracellular mechanism to limit function (e.g. rapid 
inactivation and dismemberment following synthesis; see below), and second, that mTECs 
would have a shorter lifespan than cTECs,
53
 so there would be no medullary equivalent of 
cortical ‘nurse cells’.4  
A similarity between medullary and peripheral mechanisms of negative selection would seem 
necessary to avoid central negative selection generating unduly large ‘holes’ in the final 
repertoire.
23
 If the probability of a particular self-peptide ever being presented peripherally were 
remote, then a medullary state under which that pMHC might invoke negative selection would 
be superfluous.
54
 Indeed, Kyewski and Haskins
55
 note that: “cTECs represent a unique APC type 
in the body … . In contrast, the two major medullary APC types, DCs and mTECs, very much 
resemble peripheral APCs.” Thus it would seem appropriate to look to peripheral APCs for 
guidance on mechanisms that might exist in mTECs. 
However, when contrasting medullary negative selection of developing thymocytes with the 
negative selection of mature peripheral lymphocytes, another difference emerges. Despite 
possible shifts in optimum dosage (see above), a peripheral lymphocyte interacting with pMHC 
can be deemed as held within a narrow time-window within which there must be a decision 
between positive activation and negative selection. On the other hand, for cells of the post-
positive selection thymocyte repertoire that enter the medulla there is only one fail/pass decision 
to be made – either be negatively selected or not. This would seem to require some pMHC dose 
on mTECs, but not necessarily a high pMHC dose. We are then returned to the “MHC 
ligandome” dilemma referred to above, which would seem better resolved by ascribing 
differences in cortical and medullar selections to qualitative differences in peptides.
4
 However, 
this problem can be addressed if we ascribe the need for high antigen dosage to a critical 
intracellular event that surface pMHC dosage comes to reflect. 
INTRACELLULAR SELF/NOT-SELF DISCRIMINATION   
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Given that peripheral APCs can present both self pMHC and non-self pMHCs, it is easy to 
suppose that the key to self/not-self discrimination is the central ‘educational’ process that 
creates a T lymphocyte repertoire that does not respond immunologically to self, but does 
respond to not-self. However, a mechanism for over-riding distracting self pMHCs in favour of a 
rare non-self pMHC, would seem advantageous.
20,56 
 Thus, the processing of self pMHCs 
responsible for the ‘tonic’ stimulation of T-cells in the periphery should somehow differ, either 
absolutely or in degree, from the processing of pMHCs derived from proteins deemed not-self.  
There is now evidence that, prior to appearance at the APC surface, there is intracellular 
clustering of pMHC complexes with the same peptide cargo (i.e. cognate pMHC complexes 
cosegregate internally). Lu et al.
6
 regard this as “our most important finding,” and Ferez et al. 7 
find as the “more important implication” that the peptide-specific clustering “is indicative of 
intracellular enrichment.” Noting that the “exact mechanism causing the cognate pMHC 
enrichment remains unclear,” Ferez et al. suggest that “it may result from the burst of viral 
protein expression that peaks a few hours post-infection. This burst could lead to a preferential 
loading of newly synthesized MHC class I complexes with viral peptides.” In other words, a 
virus that expresses its proteins in a burst automatically identifies itself to the host as ‘not-self’! 
However, the proposed “enrichment” of “identical peptides” raises the possibility of a special 
mechanism for their intracellular colocation to separate them from other more diffusely 
distributed peptides (i.e. the possibility of a specific intracellular discriminatory process that is 
not so easily subverted). This colocation mechanism could act at the level of diffusely distributed 
individual pMHC complexes, or could occur earlier. There is only one copy of a particular 
peptide within a protein, which often displays only that one peptide. So the colocation could first 
occur at the level of the individual peptides once they had each been released from diffusely 
distributed donor protein molecules. Alternatively, the colocation could first occur at the level of 
the donor proteins, so that the released peptides would then be available in close proximity for 
formation of cognate pMHC clusters. A mechanism consistent with the latter alternative
5
 is 
discussed below.  
If there were an intracellular self/not-self discrimination process, it could have first evolved at 
a primitive unicellular level where it would have served to rapidly limit the function of 
components of an intracellular pathogen and/or to trigger host apoptosis. The latter would 
altruistically militate against spread of the pathogen to neighbouring members of the species that 
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shared host genes.
57
 Even supposing that the ‘hand of evolution’ had conjured up such a 
mechanism, it alone would not have sufficed in multicellular organisms where something 
equivalent to a pMHC display would have served to inform an entire organism that one of it cells 
contained something designated as ‘not-self.’ The primitive T cells that recognized that cell, 
would not only kill the cell, but would be stimulated to divide, so producing more T cells of the 
same specificity, which could then, both seek other cells that displayed the same foreign pMHC, 
and establish immunological memory. Thus, immediate apoptosis triggered by an intracellular 
self/not-self discrimination event would seem counter-productive. 
INTRACELLULAR AGGREGATION HYPOTHESIS 
Building on studies of the specificity of the aggregation of erythrocytes into rouleaux by proteins 
and other agents that do not directly interact with the erythrocytes,
8,58
 the problem of 
intracellular self/not-self discrimination in the ‘crowded’ intracellular environment was 
addressed in the decade after the discovery of the association of peptides with MHC 
proteins.
20,59,60
 Cytosolic proteins are deemed to exert a collective pressure tending to make 
individual protein species coaggregate (self-assemble) when their concentrations exceed their 
individual solubility limits. These concentrations have been fine-tuned to the concentrations of 
their evolutionary ‘fellow travellers,’ so as not to exceed these limits. Not-self proteins more 
readily ‘trip’ this intracellular surveillance system because their concentrations have not been so 
fine-tuned.
5
 When a virus infects a cell, at best, this process results in pMHC display and the 
destruction of the cell; at least, the virus is forced to mutate in order to avoid identification as 
not-self, and the mutated form may proliferate less well.
61,62
  
When macromolecules in solution reach a critical concentration it becomes energetically more 
favourable for them to aggregate, like-with-like, than to remain in simple solution. The 
aggregation involves liberation of bound water and an increase in entropy. Being primarily 
entropy driven, the aggregation is promoted by an increase in temperature.
63
 That the crowded 
cytosol constitutes an environment which readily drives proteins out of solution when they 
exceed individual concentration thresholds, is well recognized from the difficulties encountered 
when trying to over-express proteins within foreign cytosols using expression vectors. Lowering 
culture temperature is a common strategy to overcome this. Likewise, increasing an organism’s 
temperature (pyrexia) can be seen as a short-term strategy for increasing the probability of 
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aggregation when the adaptive value of recognizing foreign may be greater than that of avoiding 
self-reactivity. Furthermore, an organism retains the option of ‘declaring’ one of its own self 
proteins ‘foreign’ should its sequence or expression change (due to mutation).  
The exquisite like-with-like specificity that intracellular aggregation can achieve is now well 
documented.
64
 Such homoaggregation often results in loss of function. But the scale of the 
aggregation in APC envisaged here (‘microaggregation’), suggests experimental detection would 
not be easy. However, macroscopic aggregates (‘inclusion bodies’) are a feature of various 
clinical conditions (e.g. Parkinson’s disease). Although prior homoaggregation occurs 
independently of the formation of inclusion bodies, which can contain various proteins, their 
presence provides a measure of the predisposing aggregation process. If factors promoting or 
impeding the formation of such macro-aggregates similarly affect pMHC displays in infected 
cells, this can be construed as indirectly supporting the view that micro-aggregation is a 
necessary stepping stone leading to those displays. Rather than repeat previous arguments for the 
aggregation hypothesis,
5,21
 the present paper draws attention to recent work supporting the 
stepping stone viewpoint that aggregation first marks a protein as ‘not-self,’ and this is an 
essential prerequisite for the display of one or more of its peptides as pMHCs.  
NEW EVIDENCE ON AGGREGATION 
Predicting tight control of intracellular protein concentrations, the aggregation hypothesis 
focused on the evolution of sex chromosome dosage compensation.
60
 Evidence for a 
chromosomal, rather than hormonal, basis for sex differences in the incidence of autoimmune 
diseases,
65
 now supports the view that failure of human females to adequately turn-off one X 
chromosome, so increasing aggregation pressure, could explain their marked predisposition to 
autoimmune diseases.
66
  Consistent with this, males with chromosomal anomalies such that there 
are two X chromosomes, are also predisposed.
67
 
Since one of the roles of heat shock proteins (HSPs) is to chaperone intracellular proteins and 
reverse their aggregation, the existence of a class of inducible HSPs that would promote 
aggregation was postulated.
68
 Their induction would associate with the pyrexia accompanying an 
antigenic challenge, and their experimental or therapeutic elimination would decrease 
aggregation and hence could be of value when studying or treating autoimmune diseases. 
Vitiligo (patches of white skin) is a positive prognostic factor in patients with melanoma 
tumours, indicating immune attack directed both against tumor antigens and those of pigmented 
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skin cells. This T cell-mediated ‘collateral damage’ of skin cells is decreased when inducible 
HSP70 is inactivated, and increased when it is overexpressed.
69
 Consistent with this, overturning 
long-held contrary views, formation of the intracellular aggregates in Huntington’s disease is 
now reported to be favoured by the heat-shock response that should associate with pyrexia.
70
  
Another prediction of the aggregation hypothesis was that proteins should be under 
evolutionary constraint not only to retain specific function, but also to retain solubility and 
lifespan (required for their collective function – the exerting of aggregation pressure). Thus, 
organisms synthesizing proteins with mutations adversely affecting the latter properties, would 
be selected against.
71
 Molecular properties such as isoelectric point and size (which affect ability 
to aggregate) would be expected to vary less than predicted on the basis of known amino acid 
substitution rates. This was observed as low inter-species variation in two dimensional gel 
electrophoretic analyses of proteins,
72
 and is consistent with work showing that variance in 
mRNA concentrations is much greater than the variance in concentrations of the corresponding 
proteins.
73
 And from bioinformatic analyses, in 2012 Hoof et al.
74
 concluded that: “protein 
abundance carries more information for the prediction of protein sampling [for MHC 
presentation as peptides] than transcript levels do."  
The hypothesis that protein concentrations have evolved to contribute, and to respond, to the 
aggregation pressure exerted collectively by intracellular proteins, predicts that excess of one 
protein will cause differential aggregation of others, thus exerting pleiotropic effects (e.g changes 
in functions not necessarily related to that of the original protein
75
). Furthermore, aggregation of 
intact proteins is favoured when they are large and/or abundant, the latter being likely to 
correlate with gene expression level in terms of mRNA concentrations. In a survey of pMHCs, 
Fortier et al.
76
 found that most peptides are derived from abundant mRNAs. And peptides are 
disproportionately presented from large proteins.
74,77
  
Another prediction is that proteins contributing most to macromolecular crowding will be 
conserved by virtue of this property. This means that highly expressed proteins are likely to be 
more conserved (evolve slower) than lowly expressed proteins. The conservation affects both 
protein surface residues so that reactivity with the surfaces of other proteins is decreased 
(‘misinteraction avoidance’), and protein cores (‘misfolding avoidance’). This highly significant 
negative correlation between the expression level of a protein and its rate of evolution (the ‘E-R 
anticorrelation’) has been most studied in bacteria and yeast, but there is suggestive evidence for 
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its generality.
78,79
 There is also a highly significant negative correlation between expression level 
and the finely tuned propensity to aggregate.
80
 
If differential aggregation is the mechanism by which intracellular self/not-self discrimination 
initiates, it would be predicted that the generation of aggregrates would precede any covalent 
modifications that might lead to peptide generation by way of the proteasome-ubiquitin system 
or other channels. Although there is no direct evidence on this, recent studies in pathological 
aggregation systems indicate that ubiquitination or phosphorylation occur after aggregation.
81,82
 
This suggests a necessity for prior aggregation in order that these downstream events can occur. 
Regarding non-allelic genes, by limiting the range of proteins ectopically expressed at any 
one time, an mTEC decreases the chance of the co-aggregation of two proteins that would 
normally not be in the same tissue environment together. This would be part of the strategy of 
minimizing the number and size of potential ‘holes’ in the T cell repertoire.83 Indeed, there is 
evidence that discrete sub-sets of genes (‘coexpression groups’) with distinctive chromosomal 
locations are expressed at different time-points.
4
 These may have been selected over 
evolutionary time because they do not coaggregate. Whereas most autosomal genes are 
biallelically expressed, some autosomal genes, like female X chromosomal genes, are 
monoallelically expressed in a random manner. Biallelic or monoallelic expression as random 
alternatives in mTECs
84
 might facilitate thymocyte selection (or deletion) in heterozygotes if 
aggregation were impeded (or advanced) by the heterozygosity.  
THE AVIDITY INTERPRETATION 
Evidence for this proposed designation of a protein as not-self by specific intracellular 
aggregation is currently indirect. But assuming it to occur, there should then be a corresponding 
pMHC display. The number of pMHCs displayed should be reflective of the intracellular 
concentration of the peptide-donor protein within a peripheral APC. Given that there is a 
sufficient concentration in the first place to permit the aggregation, what is it about the 
subsequent display that reflects an intermediate concentration of a protein corresponding to a 
high affinity pMHC (hence requiring an immune response)? And what is it about the display that 
reflects a high concentration of a protein corresponding to a high affinity pMHC (hence requiring 
a tolerogenic response)?  
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Following the minimal two signal postulate,
9
 one pMHC should be stimulatory and multiple 
pMHCs would be inhibitory.
85,86
 This model is among those classified in 2013 by Bains et al.
87
 
as “p – sum,“ where “T cells continually re-assess fate decisions on the basis of multiple 
summed proximal signals from TCR-pMHC interactions.” An additional postulate was that the 
inhibition would require that the signaling receptors be in close proximity.
9
 Thus, a model for the 
shaping of lymphocyte repertoires by both positive and negative selection employed the term 
‘avidity,’ rather than ‘affinity’.1 It was held that there must be “close receptor-determinant 
interaction for a discrete period of time” – a function that relates “to the chemical affinity of the 
receptor for the determinant.” Furthermore, the “stimulation of the cell to initiate an immune 
response follows reaction of antigenic determinants with a limited number of cell-borne 
receptors,” but “at high determinant concentrations … there is increased probability of the 
simultaneous occurrence of two reactions in close proximity at the lymphocyte surface between 
cell-borne receptors and antigenic determinants.” Indeed, for thymocytes, Suzuki et al.88 
proposed that low degrees of cross-linking were required for positive selection and more 
extensive cross-linking was inhibitory. In 1997 Girao et al. noted:
89
  
“The critical parameter determining the developmental fate of thymocytes is the avidity of 
interaction between thymocyte TCR and peptide/MHC complexes of thymic stromal cells; 
low avidity interaction results in no selection and the death of thymocyte by programmed 
death, intermediate avidity results in the rescue of thymocytes from programmed death and 
positive selection, and high avidity results in negative selection. One of the original caveats 
of this model is that there may be upper and lower limits to the intrinsic affinity of a peptide 
that may prevent it from triggering the positive or negative selection of a thymocyte, 
irrespective of the density on thymic stromal cells. For example, a peptide may have such 
high affinity for thymocyte TCR that even at very low density on thymic stromal cells the 
avidity of interaction is too high for positive selection and only induces negative selection; 
conversely, a peptide may have such a low affinity for thymocyte TCR that even at 
maximum density on thymic stromal cells it is incapable of generating sufficient avidity for 
positive or negative selection.”  
Their experiments lead them to conclude that “the overall avidity, and not solely the affinity of 
TCR-peptide/MHC interaction, determines the developmental fate of thymocytes.” 
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But in a later consideration of “hypotheses to resolve the selection paradox,” Klein et al.90 
distinguished models “based on the avidity or the affinity of the TCR–peptide–MHC 
interaction,” with the severe caveat: “Although the two models are frequently used 
synonymously, they are based on distinct assumptions. The avidity model predicts that the 
quantity of a given peptide–MHC complex expressed by cTECs dictates whether a thymocyte 
expressing an interacting TCR will be positively selected or deleted, whereas the affinity model 
instead postulates a crucial role of the quality of the individual TCR–peptide–MHC interaction.” 
However, recent progress in the field seems to have led the authors to refer to “affinity and/or 
avidity,” and to write simply of “strong interactions” and “weak interactions”.4  
Indeed, there is now considerable evidence for cognate pMHC coexpression in membrane 
nanoclusters that crosslink TCRs during interaction between APC and a T cell.
91,92
 This tends to 
be interpreted as a means of achieving more efficient early T cell activation. Ferez et al. note:
7
 
“The detection of clusters of MHC molecules presenting identical viral peptides upon virus 
infection provides a solution to the paradox between the long-known need for multivalency 
of experimental, activating TCR ligands … and the notion that there is only a very small 
probability that a few identical pMHC complexes within a sea of irrelevant pMHC 
complexes will ever get close enough to engage the TCR in a multivalent fashion. Second, 
they support a model where the interaction between the TCR and its pMHC ligands is 
multivalent, providing a mechanism whereby cooperation between low-affinity interactions 
leads to an increased apparent affinity and thus high sensitivity.” 
Nevertheless, possible late-onset inhibitory effects, reflecting shifting dose-response 
relationships (see above), were not excluded. Since the degree of cross-linking would be less 
important in the cortex, cTECs would require much lower pMHC levels than mTECs, as is 
observed.
13
 It would also be predicted that formation of membrane nanoclusters would be less 
necessary in cTECs. Consistent with this, the expression of a marker for membrane lipid rafts 
was not maximal until a late stage of positive thymic selection.
93
 
CONCLUDING REMARKS 
Of four consecutive hypotheses – two signal,9 positive selection,1 protein-based intracellular 
self/not-self discrimination,5 and ‘antibody RNA’-based intracellular self/not-self 
discrimination94 – the first two, albeit in various guises, are now widely accepted. Indeed, 
17 
 
noting that “somewhat paradoxically, recognition of self can elicit diametrically opposed 
outcomes,” Klein et al.4 declare: “The classical affinity model of thymocyte selection offers an 
attractive conceptual framework to resolve this apparent contradiction.” However, they regret 
that “it does not take into account the fact that positive selection and negative selection mainly 
occur in discrete thymic microenvironments … the cortex and the medulla.” The present paper 
has addressed this duality in terms of a differential protein aggregation mechanism for self/not-
self discrimination that draws parallels with the aggregation phenomena found in various 
diseases and is informed by studies of lectin-lymphocyte interaction. The paper has considered 
neither the nature of ‘third signals’ that entice some CD4+ T cells to adopt other roles, nor the 
roles of non-αβ T cells, nor the putative ‘antibody’ role of RNA.57,61,83,95 Nevertheless, it is hoped 
that the proposed explanations for numerous disparate phenomena will fruitfully guide future 
experimentation. 
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